Cardiac Complication
21
2
3
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.5%
2 terminated out of 21 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (21)
Femoral Arterial Cannulation in Pediatrics
Fluid Responsiveness in Post Cardiac Surgery Patients
Cellular precOnditioning for Post-Surgical Myocardial Ischemic Complications - Observational Study
Cardiomyocyte Injury Following Acute Ischemic Stroke
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry
The INSIGHT Feasibility Study Ultrasound in the Intensive Care Unit: A Randomised Controlled Feasibility Trial
Cardiovascular Implications of COVID-19
Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
STUDIO DELLE MANIFESTAZIONI CARDIOVASCOLARI A LUNGO TERMINE MEDIANTE TECNICHE DI IMAGING
The Quality of Recovery-15 Survey After Cardiac Surgery
One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia
Trimodal Prehabilitation in Patients Undergoing Elective Surgery
Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
Acute Effect of Positive Expiratory Pressure Versus Breath Stacking Technique After Cardiac Surgery
Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse Reactions
Evaluation of Reporting of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors Associated Cardiovascular Adverse reactioN.
Cardiac Dysfunction in Traumatic Brain Injury
Cardiac Complication After Vascular Surgery